Half-year report · Q2
4021.TEDINET S100UPZ2
Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥118.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥226.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥105.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥28.3bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥24.1bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥27.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥51.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥26.2bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥28.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥26.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥20.5bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥19.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥20.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥19.7bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥311.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥323.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥292.1bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥79.8bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥92.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥231.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥231.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥225.9bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥30.4bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥46.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥36.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥31.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥22.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥36.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥148.78 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.82 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥139.55 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥12.0bn |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.5bn |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥34m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥59.1bn |
| Reconciling Itemsreconciling | revenue external | 2024-04-01 → 2024-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥46.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.2bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥39.2bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥32.1bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.0bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.2bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥17.9bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥379m |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥48.6bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥36.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥12.6bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.4bn |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥74m |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥56.3bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥43.0bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥177.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥130.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥46.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.6bn |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥12.3bn |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7.6bn |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥158m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥52.6bn |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2023-09-30 | −¥13.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥39.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥35.3bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥11.6bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥17.9bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥11.9bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥86m |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥40.5bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥32.9bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7.7bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥11.1bn |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥57m |
| jpcrp040300-q2r_E00759-000Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥48.8bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥36.6bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥12.2bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥158.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥119.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥39.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 583
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)一単元（100株）未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)日産化学株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都中央区日本橋2-5-1 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Creditors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding receipts from contingent consideration (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |